Lord, Abbett & Co’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.1M | Buy |
+557,966
| New | +$20.1M | 0.06% | 288 |
|
2022
Q1 | – | Sell |
-195,212
| Closed | -$3.71M | – | 688 |
|
2021
Q4 | $3.71M | Sell |
195,212
-1,118,576
| -85% | -$21.3M | 0.01% | 569 |
|
2021
Q3 | $43.7M | Sell |
1,313,788
-1,512,974
| -54% | -$50.4M | 0.1% | 286 |
|
2021
Q2 | $110M | Sell |
2,826,762
-1,868,539
| -40% | -$72.5M | 0.26% | 108 |
|
2021
Q1 | $226M | Buy |
4,695,301
+254,842
| +6% | +$12.3M | 0.58% | 25 |
|
2020
Q4 | $231M | Sell |
4,440,459
-558,067
| -11% | -$29M | 0.61% | 21 |
|
2020
Q3 | $134M | Buy |
4,998,526
+3,671,841
| +277% | +$98.3M | 0.43% | 52 |
|
2020
Q2 | $25.8M | Buy |
1,326,685
+380,921
| +40% | +$7.42M | 0.09% | 336 |
|
2020
Q1 | $9.31M | Buy |
+945,764
| New | +$9.31M | 0.04% | 452 |
|
2015
Q4 | – | Sell |
-234,829
| Closed | -$2.37M | – | 945 |
|
2015
Q3 | $2.37M | Sell |
234,829
-158,479
| -40% | -$1.6M | 0.01% | 829 |
|
2015
Q2 | $6.53M | Buy |
+393,308
| New | +$6.53M | 0.02% | 724 |
|